Qing Sarah Yuan

Insider Reports History

Entity
Individual
Location
C/O Sigilon Therapeutics, Inc., 100 Binney Street, Suite 600, Cambridge, MA
Signature
/s/ Matthew Kowalsky, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Qing Sarah Yuan:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Sigilon Therapeutics, Inc. CTOO Common Stock 0 Aug 11, 2023 Direct
Sigilon Therapeutics, Inc. CTOO Stock Option (Right to Buy) 0 $0.75 Aug 11, 2023 Direct

Insider Reports Filed by Qing Sarah Yuan

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SGTX Sigilon Therapeutics, Inc. Aug 11, 2023 2 -$6.63K 4 Aug 11, 2023 CTOO
SGTX Sigilon Therapeutics, Inc. Jul 27, 2023 2 $55.5K 4 Jul 27, 2023 CTOO
SGTX Sigilon Therapeutics, Inc. Feb 28, 2023 1 $0 4 Mar 1, 2023 CTOO
SGTX Sigilon Therapeutics, Inc. Apr 1, 2022 1 $0 4 Apr 4, 2022 CTOO
SGTX Sigilon Therapeutics, Inc. Mar 7, 2022 0 $0 3 Mar 10, 2022 CTOO